BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9202608)

  • 1. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.
    Connolly AM; Pestronk A; Mehta S; Pranzatelli MR; Noetzel MJ
    J Pediatr; 1997 Jun; 130(6):878-84. PubMed ID: 9202608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Posner JB
    J Pediatr; 1997 Jun; 130(6):855-7. PubMed ID: 9202603
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
    Antunes NL; Khakoo Y; Matthay KK; Seeger RC; Stram DO; Gerstner E; Abrey LE; Dalmau J
    J Pediatr Hematol Oncol; 2000; 22(4):315-20. PubMed ID: 10959901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report.
    Salmaggi A; Nemni R; Pozzi A; Silvani A; Forno MG; Luksch R; Confalonieri P; Boiardi A
    Tumori; 1997; 83(3):709-11. PubMed ID: 9267493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
    Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
    Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
    J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
    Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
    Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to ACTH in opsoclonus-myoclonus.
    Pranzatelli MR; Kao PC; Tate ED; Chaves E; Chez M; Dobyns WB; Kang H; Rothner DA
    Neuropediatrics; 1993 Jun; 24(3):131-3. PubMed ID: 8395029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma].
    Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Plénat F; Vespignani H
    Presse Med; 1999 Feb; 28(7):330-3. PubMed ID: 10083874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of opsoclonus-myoclonus syndrome associated with anti-central nervous system antibody].
    Ushiyama M; Ishida K; Ikeda S; Imai H; Yanagisawa N
    Rinsho Shinkeigaku; 1994 Sep; 34(9):898-902. PubMed ID: 7820964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.
    Fisher PG; Wechsler DS; Singer HS
    Pediatr Neurol; 1994 Jun; 10(4):309-12. PubMed ID: 8068157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neurofilament protein antibodies in opsoclonus-myoclonus.
    Noetzel MJ; Cawley LP; James VL; Minard BJ; Agrawal HC
    J Neuroimmunol; 1987 Jun; 15(2):137-45. PubMed ID: 3294894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
    Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
    J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus/myoclonus: paraneoplastic syndrome of neuroblastoma.
    Janss A; Sladky J; Chatten J; Johnson J
    Med Pediatr Oncol; 1996 Apr; 26(4):272-9. PubMed ID: 8600342
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?
    Paliwal VK; Chandra S; Verma R; Kalita J; Misra UK
    J Neural Transm (Vienna); 2010 May; 117(5):613-5. PubMed ID: 20094737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic opsoclonus.
    Fisher PG; Singer HS
    Neurology; 1995 Jul; 45(7):1421-2. PubMed ID: 7677891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.